Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized by memory loss and cognitive dysfunction. The accumulation of misfolded protein aggregates including amyloid beta (Aβ) peptides and microtubule associated protein tau (MAPT/tau) in neuronal cells are hallmark...
Saved in:
Main Authors: | Wei Zhang (Author), Chengchao Xu (Author), Jichao Sun (Author), Han-Ming Shen (Author), Jigang Wang (Author), Chuanbin Yang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways
by: Akiko Idera, et al.
Published: (2023) -
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury
by: Xiao-cui Chen, et al.
Published: (2021) -
TFEB Dependent Autophagy-Lysosomal Pathway: An Emerging Pharmacological Target in Sepsis
by: Xin Liu, et al.
Published: (2021) -
The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets
by: Jianzhou Cui, et al.
Published: (2020) -
The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway
by: Jieru Lin, et al.
Published: (2024)